4.6 Article

Decreased amount of vimentin N-terminal truncated proteolytic products in parkin-mutant skin fibroblasts

Journal

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2019.10.154

Keywords

Parkinson's disease; Human skin fibroblasts; Two-dimensional gel electrophoresis; Mass spectrometry; Proteomics

Funding

  1. University of Bari
  2. Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany

Ask authors/readers for more resources

Vimentin, a member of cytoskeleton intermediate filaments proteins, plays a critical role in cell structure and dynamics. The present proteomic study reveals reduced amount of six different lengths, N-terminal truncated proteolytic products of vimentin, in the primary skin fibroblasts from two unrelated PD patients, as compared to control fibroblasts. The decreased amount of N-terminal truncated forms of vimentin in parkin-mutant fibroblasts, could contribute to impairment of cellular function, potentially contributing to the pathogenesis of Parkinson disease. (C) 2019 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available